| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006089095A3 Treating neurological disorders |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2005081699A3 Biomimetic organic/inorganic composites, processes for their production, and methods of use |
| 04/16/2009 | US20090099342 Process for Preparing Composite Particles, Composite Particles Obtained, and Their Use in a Diagnostic Test |
| 04/16/2009 | US20090098574 Functionalization of gold nanoparticles with oriented proteins, application to the high-density labelling of cell membranes |
| 04/15/2009 | EP2046816A1 Cysteine-tagged staphylococcal protein g variant |
| 04/15/2009 | CN101407549A Method for modifying antibody on gold film of micro-cantilever beam |
| 04/15/2009 | CN101407548A Method for preparing micro-cantilever beam modified with antibody |
| 04/15/2009 | CN101407547A Method for separating and purifying PEGylation recombinant modified human tumor necrosis factor |
| 04/15/2009 | CN100478359C Polyethylene glycol-interferon coupler and its preparation method |
| 04/15/2009 | CN100478358C Dipropyl phthalic acid artificial antigen and its preparation method |
| 04/14/2009 | US7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 04/14/2009 | CA1341592C Ion capture reagents and methods for performing binding assays |
| 04/09/2009 | WO2009044949A1 Method for preparing antibody monolayers which have controlled orientation using peptide hybrid |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2008054773A3 Fertility enhancement using lipid carriers and bioactive molecules |
| 04/09/2009 | WO2007111875A3 Methods for diagnosing and treating kidney and colorectal cancer |
| 04/09/2009 | US20090093619 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | US20090092632 Methods for preparing complex multivalent immunogenic conjugates |
| 04/08/2009 | EP2043693A1 N-terminal polysialylation |
| 04/08/2009 | EP2043692A2 Polysaccharide derivatives of erythropoietin |
| 04/08/2009 | EP2043616A1 N-terminal derivatisation of proteins with polysaccharides |
| 04/08/2009 | CN101405301A Conjugate comprising pharmaceutical active compound covalently bound to mucoadhesive polymer and transmucosal delivery method of pharmaceutical active compound using the same |
| 04/08/2009 | CN100475837C Branched polyglycol-amino acid oligopeptide and active derivative and medicinal composition thereof |
| 04/07/2009 | US7514540 for the concentration, separation and/or fixation of other amino acids, peptides, proteins or more complex molecules with peptidic structural units |
| 04/07/2009 | US7514533 polypeptides and the nucleotide sequence from the encoding gene, used in the diagnosis, prevention, and treatment of diseases |
| 04/07/2009 | US7514399 Use in tissue bonding and protein cross-linking and use in tissue and arterial repair, preservation of expanded internal luminal diameters, and local delivery of drugs, skin care materials, sunscreens, and cosmetics |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514249 Fluid swellable fibrous matrix containing minerals; artificial bone |
| 04/07/2009 | US7514248 Process for making organic/inorganic composites |
| 04/02/2009 | WO2008109785A3 Hiv reverse transcriptase compositions and methods |
| 04/02/2009 | CA2701034A1 Cell rolling separation |
| 04/01/2009 | EP1835926A4 Plasmin-inhibitory therapies |
| 04/01/2009 | EP1773866A4 Use of metal complexes |
| 04/01/2009 | EP1312671B1 Magnetic particles having lower limit critical solution temperature |
| 03/31/2009 | US7511094 2-methylbutyraldehyde diethyl acetal end capped polyoxyethylene glycol; polyalkylene oxide, polyivnylpyrrolidone, polyvinyl alcohol, polyoxazoline etc. endcapped with polyetherpolyamine copolymers or oligomers covalently attached to diacetal tetramethylene group |
| 03/31/2009 | US7510878 Bacillus thuringiensis gene with lepidopteran activity |
| 03/31/2009 | CA2210139C Immunogenic conjugate molecules |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/25/2009 | EP2040076A2 Substrate and method for producing the substrate |
| 03/25/2009 | CN100471521C Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 03/24/2009 | US7507794 Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2) |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/19/2009 | WO2009035347A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/19/2009 | WO2009034204A1 Peptide and protein preservation method |
| 03/19/2009 | WO2009033406A1 Modified recombinant human endostatin and its application |
| 03/19/2009 | WO2005101993A3 Metal-containing nanolayered composites, and applications thereof |
| 03/19/2009 | CA2699366A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 03/18/2009 | EP2037276A2 Cellular immunity test using peptides fixed to a solid medium |
| 03/17/2009 | US7504484 Antibodies to the PRO1561 polypeptide |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504378 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases |
| 03/17/2009 | US7504097 Interferon-alpha polypeptides and conjugates |
| 03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009012143A3 Virus derived antimicrobial peptides |
| 03/12/2009 | WO2009009668A3 Xylose reductase mutants and uses thereof |
| 03/12/2009 | WO2009004142A8 Method for fixing compounds comprising peptide bonds, such as proteins, to a microsystem, and microsystem incorporating these compounds |
| 03/12/2009 | WO2008012540A9 N-terminal polysialylation |
| 03/12/2009 | CA2698638A1 Bioresorbable and biocompatible compounds for surgical use |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 03/11/2009 | EP2032991A1 Protein biochip for the differential screening of protein-protein interactions |
| 03/11/2009 | CN101381413A Modified recombinant human endostatin and use thereof |
| 03/11/2009 | CN101381412A Polymer/recombinant human erythropoietin couple |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN100467490C Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate |
| 03/10/2009 | US7501489 cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use |
| 03/10/2009 | US7501398 Peptide; HIV-1 PR inhibitors which effectively interferes with the folding mechanism of the protein itself, thus destabilizing it and making it prone to proteolysis; acquired immune deficiency syndrome |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/05/2009 | WO2009028661A1 Molecule recognizing material and process for producing the molecule recognizing material |
| 03/05/2009 | WO2009028625A1 Method of binding protein to support using tamavidin |
| 03/05/2009 | WO2009027437A1 Liquid formulation of g-csf conjugate |
| 03/05/2009 | US20090061498 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 03/05/2009 | CA2696594A1 Liquid formulation of g-csf conjugate |
| 03/04/2009 | EP2029620A1 Ob fold domains |
| 03/03/2009 | US7498413 Polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium; applying by spraying, dusting, seed coating or broadcasting |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | US7498021 Peptide that binds to integrins |
| 02/26/2009 | WO2007041394A3 Reactive surfaces, substrates and methods for producing and using same |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/25/2009 | EP2028191A1 Peptides and compounds that bind to a receptor |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1017721B1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/25/2009 | EP0906448B1 Methods for the diagnosis and prognosis of cancer |
| 02/24/2009 | US7495082 Antibodies to PRO4349 polypeptides |
| 02/24/2009 | US7494975 A polyanion selected from a heparin, a dextran, a pentosan, resobene, curdian sulfate, or 2-naphthalene sulfonate polymer and a CD4 polypeptide with a beta-hairpin confirmation; blocking HIV interaction with coreceptors |
| 02/24/2009 | US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth |
| 02/24/2009 | CA2247820C Functionalized nanotubes |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/19/2009 | WO2008154518A3 Materials and methods for modulating protective pathways in epithelial cells |